Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve the Unaudited Financial Statements ....
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India has informed the stock exchanges that its Board of Directors will meet on Wednesday, 14 May 2025. The main agenda is to consider and approve the Unaudited Financial Statements for the quarter ended 31 March 2025 (Q4 FY25). The filing is a routine advance intimation under SEBI Listing Regulations. The trading window for dealing in the company's shares remains closed from 1 April 2025 to 16 May 2025 for designated persons.
No direct impact on the stock from this filing as no financial numbers are disclosed yet. Investors should watch the results announcement on or after 14 May 2025 for actual Q4 performance, dividend declarations, and any management commentary.